ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company's product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
Phone+1-925-4742500
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Zeltiq Aesthetics (NASDAQ:ZLTQ) Frequently Asked Questions
What is Zeltiq Aesthetics' stock symbol?
Zeltiq Aesthetics trades on the NASDAQ under the ticker symbol "ZLTQ."
Has Zeltiq Aesthetics been receiving favorable news coverage?
Press coverage about ZLTQ stock has trended positive recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Zeltiq Aesthetics earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next few days.
What other stocks do shareholders of Zeltiq Aesthetics own?
Who are Zeltiq Aesthetics' key executives?
Zeltiq Aesthetics' management team includes the folowing people:
- Mark J. Foley, President, Chief Executive Officer (Age 51)
- Taylor C. Harris, Chief Financial Officer, Senior Vice President (Age 41)
- Brent Hauser, President - North America (Age 40)
- Todd E. Zavodnick, President - International (Age 45)
- Sergio Garcia, Senior Vice President, General Counsel and Corporate Secretary (Age 55)
- Mike Fitzgerald, Senior Vice President - Global Human Resources (Age 57)
- Danika R. Harrison, Vice President - Global Marketing (Age 41)
- Carl H. Lamm, Vice President of Operations (Age 55)
- Brad Hauser, Vice President - Research and Development (Age 40)
How do I buy shares of Zeltiq Aesthetics?
Shares of ZLTQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Zeltiq Aesthetics' stock price today?
One share of ZLTQ stock can currently be purchased for approximately $56.48.
What is Zeltiq Aesthetics' official website?
How can I contact Zeltiq Aesthetics?
Zeltiq Aesthetics' mailing address is 4410 Rosewood Dr, PLEASANTON, CA 94588-3050, United States. The medical equipment provider can be reached via phone at +1-925-4742500.
MarketBeat Community Rating for Zeltiq Aesthetics (NASDAQ ZLTQ)
MarketBeat's community ratings are surveys of what our community members think about Zeltiq Aesthetics and other stocks. Vote "Outperform" if you believe ZLTQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZLTQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
